42 results about "Pulmonary Phthisis" patented technology

The present invention relates to a method of treatment of cachexia in a subject in need of treatment. More specifically, the present invention relates to the use of retinoid compounds that act on retinoid X receptors (RXRs) for the treatment of cachexia in a subject in need of treatment. The cachexia is associated with, in other words a complication of, a primary disease, condition or disorder. Primary diseases, conditions and disorders include, but are not limited to, cancer, AIDS, liver cirrhosis, diabetes mellitus, chronic renal failure, chronic obstructive pulmonary disease, chronic cardiac failure, immune system diseases (e.g., rheumatoid arthritis and systemic lupus erythematosus), tuberculosis, cystic fibrosis, gastrointestinal disorders (e.g., irritable bowel syndrome and inflammatory bowel disease), Parkinson's disease, anorexia nervosa, dementia, major depression, an aged condition and sarcopenia.

An agent for preventing / treating respiratory diseases contains, as an active ingredient, a compound represented by following Formula (I):wherein A is a group represented by L-W [wherein L is a bond or CH2; and W is O, SOn (wherein n is 0 to 2), or —NR7— (wherein R7 is hydrogen or lower alkyl)]; each of G1 and G2 is (CH2)r (wherein r is 0 to 2), provided that when n is 1, G1 and G2 may be bridged by lower alkylene; Y is a lower alkylene or (substituted) benzylidene; Z is a bond or O, provided that when Z is a bond, Y may form a 5- or 6-membered ring with carbon on the benzene ring; R1 is, for example, NO2, a lower alkoxycarbonyl, (substituted) carbamoyl, (protected) hydroxyl group, (protected) carboxyl, or (protected) N-hydroxycarbamoyl; each of R2 and R3 is hydrogen, halogen, (halogenated) lower alkyl, (halogenated) lower alkoxy or NO2; each of R4 and R5 is, for example, hydrogen, halogen, (halogenated) lower alkyl, (halogenated) lower alkoxy, CN, or lower alkylsulfonyl; and R6 is hydrogen or lower alkyl, a salt thereof or a solvate of them. It has excellent antitussive activity when used as an agent for preventing / treating respiratory diseases such as lung cancer, common cold syndrome, pulmonary tuberculosis, pneumonia, acute bronchitis or chronic bronchitis.

The invention provides a Chinese patent medicine for treating cough, asthma and tuberculosis and pertains to pharmaceuticals. The medicine is prepared by ginseng, lepidium seed, creat, bitter apricot kernel, black plum, fruit of Chinese magnoliavine, ginger-processed pinellia, earthworm, Chinese yam rhizome, walnut meat, cordate houttuynia , ballonflower, astragali, large-headed atractylode , ledeboruiella root, rosewood, arisacma consanguineum, winter blooming, gingko nut, lily, mint, fruit of purple perilla, globe amaranth, Chinese holly leaf, puff-Ball, oyster, pummelo peel, brassica alba boiss, radix stemonae, wartwort, pubescent holly root, rabdosia, zornia gibbosa spanoghe, ginger, Chinese ephedra, dyer woad root, white swallowwort, Japanese ardisia herb, black nightshade, Chinese globeflower and coix seed which are combined according to different weights. The medicine fully utilizes a prescription principle of improving immunity and disease resistance, supporting the healthy energy, reinforcing vital energy, clearing heat-toxin, promoting blood circulation for removing blood stasis, diminishing inflammation and alleviating pain, removing heat from the lung and dissolving phlegm and relieving cough and asthma and has the advantages of quick and significant curative effect, wide application and no side effect.

Whole-cell vaccines and methods for enhancing the immunogenicity of cellular microorganisms for use in producing protective immune responses in vertebrate hosts subsequently exposed to pathogenic bacteria or for use as vectors to express exogenous antigens and induce responses against other infectious agents or cancer cells. The present invention involves an additional method of enhancing antigen presentation by intracellular bacteria in a manner that improves vaccine efficacy. After identifying an enzyme that has an anti-apoptotic effect upon host cells infected by an intracellular microbe, the activity of the enzyme produced by the intracellular microbe is reduced by expressing a mutant copy of the enzyme, thereby modifying the microbe so that it increases immunogenicity.

The Chinese medicine for treating tuberculosis is one kind of medicine powder prepared with astragalus root, curcuma root, Zhejiang fritillary bulb, notoginseng, bletilla tuber and other 20 kinds of Chinese medicinal materials. The Chinese medicine of the present invention treats tuberculosis with four main symptoms of cough, hemoptysis, afternoon fever and night sweat caused by lung-Yin deficiency and qi and blood deficiency systematically. The Chinese medicine of the present invention has short treating period, fast acting, no recurrence and no toxic side effect.

A composite medicine for treating bronchitis, pneumonia, pulmonary abscess, bronchiectasis,e tc contains eucalyptus oil essence, lemonene, alpha-pinene, and medicinal auxiliary.

The invention relates to a traditional Chinese medicine composition for treating tuberculosis, and belongs to the technical field of traditional Chinese medicine. The traditional Chinese medicine composition is prepared from the following raw material medicine: hoantchy root, rhizome polygonati, lily, dwarf lilyturf turber, radix stemonae, bletilla, peach kernel, salvia miltiorrhiza, donkey-hide gelatin, wild buckwheat root, bulbus fritilariae, trichosanthes bark, and radix glehniae. The medicine is generally suitable for tuberculosis patients, particularly suitable for patients suffering from combined chronic diseases such as tubercular meningitis, diabetes, chronic liver disease, chronic renal disease, and the like, fever, night sweat, and physical weakness.

The invention discloses a traditional Chinese medicine for treating tuberculosis. The traditional Chinese medicine is prepared from the following raw materials in percentage by weight: 10-20 parts of root of straight ladybell, 5-12 parts of pericarpium citri reticulatae, 20-30 parts of radix stemonae, 10-20 parts of almond, 15-25 parts of root of rehmannia, 4-10 parts of radix ophiopogonis, 20-30 parts of mulberry bark, 8-15 parts of pinellia ternate, 6-14 parts of rhizoma anemarrhenae, 10-20 parts of radix asteris and 3-8 parts of radix platycodi. The traditional Chinese medicine for treating tuberculosis takes the radix stemonae and the mulberry bark as main medicines and is combined with other adjuvants, and the main medicines and the adjuvants act with each other to take a synergistic effect, so as to take excellent effects of strengthening spleen and tonifying lung, nourishing yin and clearing internal heat, tranquilizing yang and protecting lung, supplementing qi and promoting production of body fluid; the traditional Chinese medicine has good treating effect on patients of tuberculosis, and is durable in action, safe and free from side effect, simple in preparation method and convenient to take.

The invention discloses a Xylaria nigripes fermented liquid powder, the preparation and application thereof. The Xylaria nigripes fermented liquid powder is obtained by carrying out the liquid fermentation of Xylaria nigripes, obtaining mycelium and fermented liquid through solid-liquid separation, filtering monosaccharide, amino acid and other small-molecular organic compounds and inorganic salts of the fermented liquid by an ultrafiltration membrane, then drying and grinding. The powder is characterized in that the powder excludes mycelium, eliminates a plurality of inorganic salts, monosaccharide and amino acid of the fermented liquid and preserves the main active component of the fermented liquid such as Xylaria nigripes polysaccharide. The Xylaria nigripes fermented liquid powder can be used for preparing medicine, health care product and food for regulating immunity, improving sleep, resisting anxiety and depression, curing migraine, relieving cough, resisting inflammation and curing phthisis, HBV hepatitis, prostatitis, tumor, female dysmenorrheal and diabetes.

The invention belongs to the technical field of formulae of homology of medicine and food and new resource foods, and in particular provides a medical formula food, a specific medical formula food or a non-specific medical formula food for patients with phthisis. The formula food is processed by following the requirements of general rule of formula food for special medical purpose, combining the physical constitution of the patients with phthisis, reasonably matching a plurality of traditional Chinese medicines of homology of medicine and food according to the essence theory of traditional Chinese medicine, and mixing a plurality of edible and medical traditional Chinese medicine extract essence extracted by prehydrolysis SBE technology, a plurality of microcapsuled probiotics and biological enzymolysis extracted short peptides, prebiotics, amino acids, carbohydrates, as well as health-care grease, a plurality of vitamins and mineral substances. The medical formula food provided in the invention can meet the nutritive requirement of the patients with phthisis as a single nutritive source, and has the efficacy of strengthening spleen, tonifying lung, clearing away heat and toxic materials, invigorating spleen-stomach and replenishing qi, preventing phlegm from forming and stopping coughing, tonifying lung, clearing heat and preventing phthisis.

The invention belongs to the technical field of medicine, and relates to a method for treating the phthisis and the respiratory disease by inhaling atomized purple garlic liquid, in particular to a method for treating the phthisis through the extracting solution of purple garlic (the purple garlic liquid) and an atomizer. The purple garlic liquid is extracted at the low temperature and is atomized by the atomizer into ultramicro particles with the diameter being about 0.2 micron, the atomized liquid can fully and evenly adhere to the pulmonary alveoli and the inner walls of the bronchi through the deep breathing and medicine feeding treatment, and due to the fact that the diameter of the atomized liquid is small, the atomized liquid permeates evenly and can reach the focal zone to carry out sterilization and take part in the lung blood microcirculation, and the active ingredient allisatin of the garlic liquid is conveyed along with the blood to kill and restrain bacteria. The method solves the problems that current common oral administration anti-phthisis western medicines are large in side effect and bad in medicine resistance and curative effect and injure the liver and kidneys. The method can be applied to the pneumology department to treat bronchitis, asthma, flu, sphagitis, rhinitis, nasosinusitis and other respiratory diseases besides the phthisis and pneumonia in the pulmonary medicine. The purple garlic liquid is a very good natural medicine, and the method is very good.

The invention discloses a medicine for treating phthisis. The medicine is prepared from the following medicinal materials in mass ratio: 10-15 of concha ostreae, 15-20 of selfheal, 10-15 of alisma leaf, 20-25 of radix stemonae, 20-25 of radix asparagi, 10-15 of ophiopogon root, 10-15 of platycodon grandiflorum, 15-20 of bulbus fritillariae cirrhosae, 20-25 of radix scrophulariae, 10-15 of flos farfarae, 5-10 of liquorice, 10-15 of honeysuckle, 10-15 of pericarpium citri reticulatae, and 10-15 of schisandra chinensis. The preparation method comprises the following steps: respectively cleaning the above medicinal materials, drying, disinfecting, crushing into fragments, mixing in proportion, putting in a reactive pan, a copper pan or a wooden barrel or a cement pond, introducing steam to heat; or continuously decocting to extract effective components; preparing filtrate into extractum by using moderate heat, drying, crushing, pressing into tablets according to a conventional pharmaceutical preparation technology, or packing into capsules. The medicine for treating phthisis disclosed by the invention is obvious in curative effect, convenient for administration, and suitable for treating phthisis patients.

The invention relates to an antitubercular pharmaceutical composition containing balloonflower root extract, which is prepared from the components of 0.1-100 parts of balloonflower root extract by weight and 1 part of antitubercular drug by weight through the steps as follows: extracting the balloonflower root extract for three times by water or extracting the balloonflower root extract for three times by 40-95% ethanol at the temperature of 90 DEG C, and concentrating, wherein the weight measurement ratio of the balloonflower root extract to the water is 1:(6-10), and the weight measurement ratio of the balloonflower root extract to the ethanol is 1:(5-15). The pharmaceutical composition in the invention has the functions of enriching the antitubercular drugs in lung tissues and improving the potency of the antitubercular drugs for curing phthisis as compared with single antitubercular drugs, and simultaneously has the positive effects such as reducing the liver injury caused by the antitubercular drugs and the like. By utilizing he pharmaceutical composition, the phthisis therapeutic window of the antitubercular drugs can be amplified, and the capability of effectively killing tubercle bacillus is enhanced, thereby increasing the potency, shortening the treatment cycle and lowering the possibility of tolerance of tubercle bacillus.

The invention relates to a traditional Chinese medicine combination for curing the phthisis. The traditional Chinese medicine combination comprises, by weight, 10-40 parts of Chinese yam, 5-25 parts of radix cudramiae, 10-30 parts of longan, 10-30 parts of black fungus, 5-25 parts of cacumen biotae, 5-20 parts of andrographis paniculata, 5-25 parts of rhodiola rosea, 5-20 parts of radix ranunculi ternate, 5-20 parts of acacia catechu, 10-30 parts of bryozoatum, 5-25 parts of pollen typhae, 5-25 parts of indigo naturalis, 10-30 parts of pearl powder, 5-20 parts of ardisia japonica, 5-25 parts of crotalaria ferruginea grah, 10-30 parts of spina date seed, 5-20 parts of gallnut, 10-30 parts of kaki calyx, 5-25 parts of lepironia articulate, 5-20 parts of citron, 5-25 parts of air potato, 10-30 parts of radix peucedani and 5-20 parts of liquorice. The traditional Chinese medicine combination for curing the phthisis has the functions of spleen and lung invigorating, heating clearing and lung moistening, cough relieving and sputum reducing, qi benefiting and blood nourishing and sweating arresting and hemostasis, and is effective in treatment of phthisis and reliable in function.

The invention belongs to the technical field of medicinal preparations, and discloses dextromethorphan chewing gum tablets and an industrially applicable preparation method thereof. The preparation is delivered through a chewing process, so that the defects of the marketed products at present can be overcome, and the tablets have the advantages of no need of water for taking, convenience in taking, good mouthfeel, less adverse effects, quick response, capability of eliminating thirst and the like. The dextromethorphan chewing gum tablets prepared by the invention are mainly used for dry coughand are suitable for cold, acute or chronic bronchitis, bronchial asthma, faucitis, phthisis and cough during other upper respiratory tract infections. The dextromethorphan chewing gum tablets provided by the invention have the advantages of simple preparation process, low cost, easiness in control and easiness for industrial production.

The invention discloses a Chinese drug for the treatment of respiratory diseases, which has raw materials according to parts by weight: 1 portion to 3 portions of Chinese caterpillar fungus, respective 3 portions to 12 portions of safflower, dwarf lilyturf turber, root of rehmannia, asparagus root, prepared rhizome of rehmannia, dahurian angelica, bulbus fritilariae, donkey-hid gelatin, liquorice, abrotanum and stephania tetrandra, and 9 portions to 20 portions of lily. The drug has obvious effects over the treatment of a series of respiratory diseases, such as tuberculosis, pneumoconiosis, chronic bronchitis, pulmonary infection, and the like, and can have active preventive effect on liver and kidney dysfunction caused by chemotherapeutics and can improve the functions of liver and the kidney. Simultaneously, time of chemotherapy can be shortened and the drug tolerance of the chemotherapeutics to tubercle bacillus, and the Chinese drug has not any toxic side effects and wide adaption to diseases, and can enhance the immunologic function, shorten course of treatment and has obvious curative effect on sufferers with weak immune systems.

The invention discloses a traditional Chinese medicine, in particular a traditional Chinese medicine for treating phthisis. The traditional Chinese medicine is prepared from hoodshaped alocasia rhizome, dahurian angelica root, swallowwort rhizome, Chinese ephedra, medlar, radix platycodi, schisandra fruit, rhizoma sparganii, rhizoma zedoariae, aster, stemona root, almond, dragon's tongue leaf, astragalus root and licorice according to certain parts by weight. The invention has simple preparation, good absorption effect, obvious curative effect, no side effect and high safety and is beneficial for patients to relieving the symptoms in time.

The invention provides a stomatological treatment chair with a clean positive-pressure air curtain, and relates to a novel stomatological treatment chair which is provided with a clean positive-pressure air system, can form a downward blowing type clean air curtain between mouths and noses of a doctor and a patient and is provided with a polluted air recovering system. The stomatological treatment chair is characterized in that a pressure equalizing box with an air filtering layer is connected to the upper end of an elbow which is fixed to the rear surface of a headrest; the lower end of the elbow is connected with a positive-pressure air valve and then is connected with the clean positive-pressure air system; corresponding vacuum branch tubes at two sides of a seat board are connected with a main vacuum tube; a filtering net is arranged in a vacuum absorbing head which is connected to a vacuum valve at an upper head of each vacuum branch tube. With the adoption of the stomatological treatment chair with the clean positive-pressure air curtain, water mist containing saliva, blood and bacteria of the patient can be prevented from spreading between the doctor and the paint; particularly, the stomatological treatment chair has an important social significance on preventing infectious diseases spread by the ways above, such as venereal disease, aids, influenza hepatitis B and phthisis. The stomatological treatment chair is novel in structure design, practical, scientific and reasonable; the treatment quality and level of a department of stomatology of a modern hospital can be improved; the stomatological treatment chair is suitably popularized and applied to the department of stomatology of the hospital at all levels and the dental clinics.

A Chinese medicine in the form of particle or others for treating pulmonary tuberculosis is prepared from 6 Chinese-medicinal materials including dandelion herb, fleece flower root, stemona root, bletilla tuber, etc. Its preparing process is also disclosed.

The invention discloses a medicinal preparation for treating phthisis, which is characterized by comprising the following raw material medicaments in part by weight: 1 to 100 parts of corylifolinin and 1 to 100 parts of salvianic acid A sodium. Pharmacological tests show that the medicinal preparation has good effect of treating phthisis.

The invention provides a traditional Chinese medicine composition for treating phthisis. The traditional Chinese medicine composition is prepared from the following components: house liyard powder, radix stemonae, rhizoma bletillae, lily and bulbus fritillariae cirrhosae. The traditional Chinese medicine composition has the efficacies of nourishing the lung, promoting the secretion of saliva or body fluid, resisting tuberculosis and killing pests; and the clinical effective rate is 91%.

The invention discloses a Xylaria nigripes fermented liquid powder, the preparation and application thereof. The Xylaria nigripes fermented liquid powder is obtained by carrying out the liquid fermentation of Xylaria nigripes, obtaining mycelium and fermented liquid through solid-liquid separation, filtering monosaccharide, amino acid and other small-molecular organic compounds and inorganic salts of the fermented liquid by an ultrafiltration membrane, then drying and grinding. The powder is characterized in that the powder excludes mycelium, eliminates a plurality of inorganic salts, monosaccharide and amino acid of the fermented liquid and preserves the main active component of the fermented liquid such as Xylaria nigripes polysaccharide. The Xylaria nigripes fermented liquid powder canbe used for preparing medicine, health care product and food for regulating immunity, improving sleep, resisting anxiety and depression, curing migraine, relieving cough, resisting inflammation and curing phthisis, HBV hepatitis, prostatitis, tumor, female dysmenorrheal and diabetes.

The invention discloses traditional Chinese medicine condensed decoction with a cough relieving function and a preparation method thereof. The formula comprises bulbus fritillariae cirrhosae fluid extract 1%-5%, lotus leaf extracting solution 10%-25%, fermented Chinese caterpillar fungus powder 5%-15%, menthol and almond essence 0.05%-0.1% and honey 55%-84%. According to the condensed decoction, the dosage form is honey-refined condensed decoction, the condensed decoction has good mouth feeling and is a good lung moistening and cough relieving product for treating in consideration of health care, and the condensed decoction is capable of tonifying lung and kidney, is used for treating cough caused by yin deficiency, chronic cough, fatigue, excessive use of throat, excessive smoking and thelike and can also be used as an adjuvant drug for chemotherapy for tuberculosis and lung cancers.

The invention discloses a medicine for treating phthisis, and the medicine comprises the following main components: 15g of ephedra, 4g of asarum, 4g of fructus xanthii, 4g of rhizoma corydalis, 4g of clove, 3g of evodia, 3g of sinapis alba and 3g of cinnamon. The medicine is suitable for treating chronic lungers and can effectively relieve night cough.

The invention relates to traditional Chinese medicine treating infiltrative tuberculosis and belongs to the technical field of medicine. The problem of treating infiltrative tuberculosis is solved. The infiltrative tuberculosis is analyzed through traditional Chinese medicine viewpoints, and infiltrative tuberculosis belongs to the situation that germs enter the lung, blood vessels are damaged, pathogenic factors are gathered, evil heat association happens and evil toxin is latently gathered; traditional Chinese medicine clearing away heat and toxin, killing bacteria and eliminating phlegm, activating and cooling blood and eliminating stagnant blood and removing stasis is mainly used, and meanwhile traditional Chinese medicine benefiting qi and toinfying the kidney is used as treatment medicine. The traditional Chinese medicine treating infiltrative tuberculosis is prepared from 10 parts of honeysuckle, 10 parts of Chinese honeylocust spine, 10 parts of hedyotis diffusa, 8 parts of seaweed, 8 parts of kelp, 10 parts of roots of bidentate achyranthes, 6 parts of roots of Chinese thorowax, 15 parts of lilies, 10 parts of root bark of peony trees, 10 parts of roots of rehmannia, 12 parts of dandelions, 12 parts of Japanese ardisia and 8 parts of liquorice. The traditional Chinese medicine treating infiltrative tuberculosis is a positive solution according to the medical theory, medicine coordination succeeds, and the curative effect is remarkable.

The invention discloses lung clearing tea. The lung clearing tea is prepared from the following raw materials in parts by weight: 50g of radix rehmanniae recen, 50g of roots and seeds of Hypericum kouytchense Levl., 10g of fine leaves, 10g of lumbricus, 10g of Japanese antifeverile dichroa, 15g of hairyvein agrimony, 15g of aleppo avens, 15g of rhizoma bletillae, 10g of radix asparagi, 10g of radix ophiopogonis, 10g of berchemia lineate, 15g of platycodon grandiflorum and 10g of radix stemonae. The lung clearing tea can clear away the lung-heat, reduce phlegm, relieve asthma and cough, moistenthe lung, nourish yin, clear away the heart-fire and relieve restlessness, has a conditioning effect on phthisis, pleurisy and bone tuberculosis, and especially has a special effect on phthisis.

The invention relates to the technical field of traditional Chinese medicines and provides a traditional Chinese medicine composition for preventing tuberculosis according to the tuberculosis understanding mechanism of the traditional Chinese medicine. The traditional Chinese medicine composition is prepared from 2-4 parts by weight of polygala root, 4-8 parts by weight of a bamboo juice, 5-7 parts by weight of radix asteris, 3-5 parts by weight of reddish orange, 10-15 parts of raw coix seeds and 4-8 parts of pinellia ternate. The traditional Chinese medicine composition is decocted by water and the decoction is taken twice every day. One treatment course comprises 15 days. The traditional Chinese medicine composition utilizes easily available raw materials, has good effects, and has no side effect. Through use in hundreds of cases of tuberculosis patients, the statistics result shows that the traditional Chinese medicine composition has an effective rate of 97.5% or more.